Lee Golden
Chief Tech/Sci/R&D Officer en PTC THERAPEUTICS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Lee Scott Golden is currently the Chairman at Coagulation Sciences LLC and the Chief Medical Officer at PTC Therapeutics, Inc. He previously worked as the Medical Director at Pfizer Inc. from 2001 to 2005, Senior Director-US Medical at Actelion Pharmaceuticals US, Inc. from 2005 to 2008, Head-Cardiovascular & Blood Disorders at Eisai, Inc. from 2009 to 2011, Head-Pulmonary at Mesoblast Ltd.
from 2011 to 2016, and Chief Medical Officer at Gemphire Therapeutics, Inc. from 2016 to 2018.
He has an undergraduate degree from the University of Michigan and a doctorate degree from New York University School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.08% | 02/04/2024 | 59 988 ( 0.08% ) | 2 M $ | 31/03/2024 |
Cargos activos de Lee Golden
| Empresas | Cargo | Inicio |
|---|---|---|
| PTC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Coagulation Sciences LLC
 Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Coagulation Sciences LLC engages in the provision of blood-testing innovation solutions. It offers multiple coagulation test systems, and benefits. The company was founded by Sheldon Goldstein and is headquartered in New York, NY. | Chairman | - |
Antiguos cargos conocidos de Lee Golden.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/09/2018 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 01/10/2016 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 01/07/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/03/2008 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/01/2005 |
Formación de Lee Golden.
| University of Michigan | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
Coagulation Sciences LLC
Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Coagulation Sciences LLC engages in the provision of blood-testing innovation solutions. It offers multiple coagulation test systems, and benefits. The company was founded by Sheldon Goldstein and is headquartered in New York, NY. | Health Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Bolsa de valores
- Insiders
- Lee Golden
